137 related articles for article (PubMed ID: 36597712)
41. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
42. The recurrent p.(Pro540Ser) MEN1 genetic variant should be considered nonpathogenic: A case report.
Villabona C; Oriola J; Serrano T; Guerrero-Pérez F; Valdés N; Chiara M; Robledo M
Am J Med Genet A; 2021 Dec; 185(12):3872-3876. PubMed ID: 34313384
[TBL] [Abstract][Full Text] [Related]
43. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
44. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.
Prezant TR; Levine J; Melmed S
J Clin Endocrinol Metab; 1998 Apr; 83(4):1388-91. PubMed ID: 9543172
[TBL] [Abstract][Full Text] [Related]
45. A novel germline mutation of the MEN1 gene caused multiple endocrine neoplasia type 1 in a Chinese young man and 1 year follow-up.
Liu W; Han X; Hu Z; Zhang X; Chen Y; Zhao Y; Ji L
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):3111-6. PubMed ID: 24302194
[TBL] [Abstract][Full Text] [Related]
46. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
47. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.
De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI
Eur J Endocrinol; 2017 May; 176(5):635-644. PubMed ID: 28220018
[TBL] [Abstract][Full Text] [Related]
48. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
49. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
50. p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Nozières C; Zhang CX; Buffet A; Dupasquier S; Vargas-Poussou R; Guillaud-Bataille M; Cordier-Bussat M; Ruszniewski P; Christin-Maitre S; Murat A; Groussin L; Vezzosi D; Cardot-Bauters C; Hervieu V; Joly MO; Giraud S; Odou MF; Gimenez-Roqueplo AP; Goudet P; Borson-Chazot F; Calender A;
Ann Endocrinol (Paris); 2014 Jul; 75(3):133-40. PubMed ID: 24997771
[TBL] [Abstract][Full Text] [Related]
51. Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.
Falchetti A; Marini F; Luzi E; Giusti F; Cavalli L; Cavalli T; Brandi ML
Genet Med; 2009 Dec; 11(12):825-35. PubMed ID: 19904212
[TBL] [Abstract][Full Text] [Related]
52. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
53. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
54. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
[TBL] [Abstract][Full Text] [Related]
55. Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred.
Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
Am J Med; 1996 May; 100(5):544-7. PubMed ID: 8644767
[TBL] [Abstract][Full Text] [Related]
56. Pituitary tumours in MEN1 syndrome - the new insight into the diagnosis and treatment.
Rogoziński D; Gilis-Januszewska A; Skalniak A; Kluczyński Ł; Pantofliński J; Hubalewska-Dydejczyk A
Endokrynol Pol; 2019; 70(5):445-452. PubMed ID: 31681967
[TBL] [Abstract][Full Text] [Related]
57. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
58. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
Hao W; Skarulis MC; Simonds WF; Weinstein LS; Agarwal SK; Mateo C; James-Newton L; Hobbs GR; Gibril F; Jensen RT; Marx SJ
J Clin Endocrinol Metab; 2004 Aug; 89(8):3776-84. PubMed ID: 15292304
[TBL] [Abstract][Full Text] [Related]
59. Large genomic deletions in AIP in pituitary adenoma predisposition.
Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
[TBL] [Abstract][Full Text] [Related]
60. Pituitary gigantism caused by growth hormone excess from infancy.
Gelber SJ; Heffez DS; Donohoue PA
J Pediatr; 1992 Jun; 120(6):931-4. PubMed ID: 1593354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
